Consequently, to find the association of ANRIL variants with breast cancer susceptibility in Iranian patients, we genotyped and examined the association of rs1333045, rs4977574, rs1333048 and rs10757278 according to their significance in the regulation of ANRIL expression and their participation in breast cancer-related pathways. This evidence concerns the gene CDKN2B-AS1 and breast carcinoma.